Skip to main content
SpringerLink
Log in

Remarks on the screening of antibiotics for antibacterial activity

  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

The general principles of screening antibiotics for antimicrobial activity are similar to those for screening for other pharmacological effects. The system should be adapted to the specific character of the test substance and the objectives of the program. In the screening of β-lactams, standard tests, such as determination of the MICs, effects of inoculum size or activity against systemic infection in mice, should be supplemented by less conventional studies on for instance activity against dormant bacteria or, in the case of penems or carbapenems, stability in the presence of kidney and lung dehydropeptidases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Zak O, Lang M, Cozens R, Konopka EA, Mett H, Schneider P, Tosch W, Scartazzini R: Penems: in vitro and in vivo experiments. Journal of Clinical Pharmacology 1988, 28: 128–135.

    Google Scholar 

  2. Wold S: General discussion of conference. In: Jolles G, Woolridge KRH (ed): Drug design: fact or fantasy. Academic Press London, 1984, p. 253–254.

    Google Scholar 

  3. Hajdu R, Hayase K, Sundelof J, Kropp H, Kahan F: Cilastatin-sensitive lactamase active on carbapenem and penem antibiotics in the lung of rodents. In: Ishigami J (ed): Recent advances in chemotherapy. University of Tokyo Press, 1985, p. 1211–1212.

  4. Kahan FM, Kropp H, Sundelof JG, Birnbaum J: Thienamycin: development of imipenem-cilastatin. Journal of Antimicrobial Chemotherapy 1983, 12, Supplement D: 1–35.

    Google Scholar 

  5. Richmond MH, Sykes RB: the beta-lactamases of gram-negative bacteria and their possible role. Advances in Microbial Physiology 1973, 9: 31–88.

    Google Scholar 

  6. Then RL, Angehrn P: Trapping of nonhydrolyzable cephalosporins by cephalosporinases inEnterobacter cloacae andPseudomonas aeruginosa as possible resistance mechanism. Antimicrobial Agents and Chemotherapy 1982, 21: 711–717.

    Google Scholar 

  7. Sawai T, Yoshida T, Tsukamoto K, Yamagishi S: A set of bacterial strains for evaluation of β-lactamase stability of β-lactam antibiotics. Journal of Antibiotics 1981, 34: 1318–1326.

    Google Scholar 

  8. Richmond MH, Jack GW, Sykes RB: The β-lactamase of gram-negative bacteria including pseudomonads. Annals of the New York Academy of Sciences 1971, 182: 243–257.

    Google Scholar 

  9. Calderwood SB, Gardella A, Philippon AM, Jacoby GA, Moellering RC: Effects of azlocillin in combination with clavulanic acid, sulbactam, and N-formimidoyl thienamycin against β-lactamase producing, carbenicillin-resistantPseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 1982, 22: 266–271.

    Google Scholar 

  10. Boman HG, Monner DA: Characterization of lipopolysaccharides fromEscherichia coli K-12 mutants. Journal of Bacteriology 1975, 121: 455–464.

    Google Scholar 

  11. Pugsley AP, Schnaitman CA: Identification of three genes controlling production of new outer membrane pore proteins inEscherichia coli K-12. Journal of Bacteriology 1978, 135: 1118–1129.

    Google Scholar 

  12. Suzuki H, Nishimura Y, Hirota Y: On the process of cellular division inEscherichia coli: a series of mutants ofEscherichia coli altered in the penicillin-binding proteins. Proceedings of the National Academy of Sciences USA 1978, 75: 664–668.

    Google Scholar 

  13. Godfrey AJ, Bryan LE: Mutation ofPseudomonas aeruginosa specifying reduced affinity for penicillin G. Antimicrobial Agents and Chemotherapy 1982, 21: 216–223.

    Google Scholar 

  14. Tuomanen E, Schwartz J: Penicillin-binding protein 7 and its relationship to lysis of nongrowingEscherichia coli. Journal of Bacteriology 1987, 169: 4912–4915.

    Google Scholar 

  15. Zak O, Sande MA: Correlation of in vitro antimicrobial activity with results of treatment in experimental animal models and human infection. In: Sabath LD (ed): Action of antibiotics in patients. Hans Huber, Bern, 1982, p. 55–67.

    Google Scholar 

  16. Tuomanen E: Phenotypic tolerance: the search for β-lactam antibiotics that kill nongrowing bacteria. Reviews of Infectious Diseases 1986, 8 Supplement 3: 279–291.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Research Department, Pharmaceuticals Division, Ciba-Geigy Ltd., CH-4002, Basel, Switzerland

    O. Zak, H. Mett & T. O'Reilly

Authors
  1. O. Zak
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Mett
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. O'Reilly
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zak, O., Mett, H. & O'Reilly, T. Remarks on the screening of antibiotics for antibacterial activity. Eur. J. Clin. Microbiol. Infect. Dis. 9, 462–465 (1990). https://doi.org/10.1007/BF01964284

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01964284

Keywords

Search

Navigation